BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32514165)

  • 1. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
    Suster D; Michal M; Huang H; Ronen S; Springborn S; Debiec-Rychter M; Billings SD; Goldblum JR; Rubin BP; Michal M; Suster S; Mackinnon AC
    Mod Pathol; 2020 Dec; 33(12):2520-2533. PubMed ID: 32514165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep sequencing of myxoinflammatory fibroblastic sarcoma.
    Arbajian E; Hofvander J; Magnusson L; Mertens F
    Genes Chromosomes Cancer; 2020 May; 59(5):309-317. PubMed ID: 31898851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
    Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
    Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
    Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
    Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
    Hallor KH; Sciot R; Staaf J; Heidenblad M; Rydholm A; Bauer HC; Aström K; Domanski HA; Meis JM; Kindblom LG; Panagopoulos I; Mandahl N; Mertens F
    J Pathol; 2009 Apr; 217(5):716-27. PubMed ID: 19199331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
    Nishio J; Nakayama S; Aoki M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates.
    Ieremia E; Thway K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1406-11. PubMed ID: 25268202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
    Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
    Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
    Liu H; Sukov WR; Ro JY
    Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes.
    Lambert I; Debiec-Rychter M; Guelinckx P; Hagemeijer A; Sciot R
    Virchows Arch; 2001 May; 438(5):509-12. PubMed ID: 11407481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions.
    Klubíčková N; Agaimy A; Hájková V; Ptáková N; Grossmann P; Šteiner P; Michal M; Michal M
    Virchows Arch; 2022 Oct; 481(4):613-620. PubMed ID: 35776191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
    Wangsiricharoen S; Ali SZ; Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.
    Laskin WB; Fetsch JF; Miettinen M
    Am J Surg Pathol; 2014 Jan; 38(1):1-12. PubMed ID: 24121178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality.
    Ida CM; Rolig KA; Hulshizer RL; Van Dyke DL; Randolph JL; Jenkins RB; Nascimento AG; Oliveira AM
    Cancer Genet Cytogenet; 2007 Sep; 177(2):139-42. PubMed ID: 17854670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments.
    Mansoor A; Fidda N; Himoe E; Payne M; Lawce H; Magenis RE
    Cancer Genet Cytogenet; 2004 Jul; 152(1):61-5. PubMed ID: 15193443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children.
    Zhang M; Yu Y; Guan X; Yao X; Jia C; Hong E; Guo Y; He L
    Pathol Res Pract; 2022 Feb; 230():153754. PubMed ID: 34990868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.